Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

NCT ID: NCT06852378

Last Updated: 2025-03-04

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 80 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-03-01
• Study Completion Date: 2026-02-01

Brief Summary

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Detailed Description

Hip fractures are among the most frequent fractures seen in the emergency department and orthopedic trauma teams. The terms hip fracture and neck of femur fracture are used synonymously. Both terms describe a proximal femur fracture between the femoral head and 5 cm distal to the lesser trochanter.

Iliopsoas nerve Block (IPB) is a promising motor-sparing analgesic technique that selectively targets the sensory branches of the hip joint originating from the femoral nerve and accessory obturator nerve, sparing the motor supply of quadriceps muscles.

A femoral nerve block (FNB) is a simple nerve block that can be performed easily without or under ultrasound guidance. Under ultrasound guidance, the femoral artery and femoral nerve were identified clearly, and a needle was inserted using an in-plane approach from the lateral to the medial direction. Once the needle tip's position was confirmed, 10 ml of 0.5% bupivacaine was injected adjacent to the femoral nerve.

Conditions

Iliopsoas Nerve Block; Femoral Nerve Block; Hip Fracture Surgeries

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Iliopsoas nerve block group

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Iliopsoas nerve block

Intervention Type: DRUG

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Femoral nerve block group

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Femoral nerve block

Intervention Type: DRUG

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Interventions

Iliopsoas nerve block

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Intervention Type: DRUG

Femoral nerve block

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Intervention Type: DRUG

Other Intervention Names

Bupivacaine 0.5%; Bupivacaine 0.5%

Eligibility Criteria

Inclusion Criteria

• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I and II.
• Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

Exclusion Criteria

• Refusal to participate.
• Coagulopathy.
• Patients with a history of drug allergies to study drugs.
• Inability to cooperate.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ain Shams University

OTHER

Sponsor Role: lead

Responsible Party

Hazem Khaled Abdelrazek Saeed

Assistant Lecturer of Anesthesia, Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Ain Shams University

Cairo, , Egypt

Site Status: RECRUITING

Countries

Egypt

Central Contacts

Hazem K Saeed, Master

Role: CONTACT

hazem.khaled@med.asu.edu.eg

00201016056123

Facility Contacts

Hazem K Saeed, Master

Role: primary

hazem.khaled@med.asu.edu.eg

00201016056123

Other Identifiers

FMASU MD38/2025

Identifier Type: -

Identifier Source: org_study_id